文献速递眼底病与葡萄膜炎

PDE6A相关视网膜色素变性的中心视觉功能与基因型-表型相关性

Central Visual Function and Genotype-Phenotype Correlations in PDE6A-Associated Retinitis Pigmentosa.
PubMed 文献 · Invest Ophthalmol Vis Sci · 2022-01-01

研究纳入44例经基因确诊的PDE6A相关常染色体隐性视网膜色素变性患者,平均年龄43±13岁,评估最佳矫正视力、对比敏感度和色觉。结果显示c.304C>A/p.R102S纯合患者中心视觉功能优于c.998+1G>A/p.?纯合患者,尽管前者基线年龄更大;中心视觉功能年下降率较小。作者据此对不同PDE6A突变的严重程度进行了排序。

要点

  • c.304C>A/p.R102S纯合患者中心视觉功能优于c.998+1G>A/p.?纯合患者,尽管前者基线年龄更大。
  • c.304C>A/p.R102S纯合与c.304C>A/p.R102S及c.2053G>A/p.V685M复合杂合患者中心视觉功能相似,尽管后者基线更年轻。
  • 中心视觉功能年下降率较小,作者认为这将使干预试验的疗效评估具有挑战性。

核心结论

  • 不同PDE6A致病突变对人类中心视觉功能的严重程度排序可能为:c.2053G>A/p.V685M纯合(最重)> c.998+1G>A/p.?纯合 > c.304C>A/p.R102S与c.2053G>A/p.V685M复合杂合 > c.304C>A/p.R102S纯合(最轻)。
  • 由于中心视觉功能年下降率较小,干预试验中治疗疗效的评估将仍具挑战性。

研究设计与样本

  • 研究纳入44例经基因确诊的PDE6A相关常染色体隐性视网膜色素变性患者,其中女性26例,平均年龄±标准差为43±13岁。
  • 患者接受全面眼科检查,包括早期治疗糖尿病视网膜病变研究视力表测最佳矫正视力、Pelli-Robson对比敏感度表在3米和1米距离测试、以及Roth 28-Hue和Panel D-15饱和色杯色觉测试。

主要发现

  • 最常见的变异为c.998+1G>A/p.?、c.304C>A/p.R102S和c.2053G>A/p.V685M。
  • c.304C>A/p.R102S纯合患者中心视觉功能优于c.998+1G>A/p.?纯合患者,尽管前者基线年龄更大。
  • c.304C>A/p.R102S纯合患者与c.304C>A/p.R102S及c.2053G>A/p.V685M复合杂合患者中心视觉功能相似,尽管后者基线年龄更小。
  • 中心视觉功能的年下降率较小。

临床怎么用

  • 原文未据此给出推荐。

局限性

  • 原文未报告局限性。

以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。

原文

PURPOSE: Autosomal recessive retinitis pigmentosa (arRP) can be caused by mutations in the phosphodiesterase 6A (PDE6A) gene. Here, we describe the natural course of disease progression with respect to central retinal function (i.e., visual acuity, contrast sensitivity, and color vision) and establish a detailed genotype--phenotype correlation. METHODS: Forty-four patients (26 females; mean age ± SD, 43 ± 13 years) with a confirmed genetic diagnosis of PDE6A-associated arRP underwent comprehensive ophthalmological examinations including best-corrected visual acuity (BCVA) with Early Treatment Diabetic Retinopathy Study charts, contrast sensitivity (CS) with Pelli-Robson charts at distances of 3 m and 1 m, and color vision testing using Roth 28-Hue and Panel D-15 saturated color cups. RESULTS: The most frequently observed variants were c.998+1G>A/p.?, c.304C>A/p.R102S, and c.2053G>A/p.V685M. Central retinal function in patients homozygous for variant c.304C>A/p.R102S was better when compared to patients homozygous for variant c.998+1G>A/p.?, although the former were older at baseline. Central retinal function was similar in patients homozygous for variant c.304C>A/p.R102S and patients heterozygous for variants c.304C>A/p.R102S and c.2053G>A/p.V685M, although the latter were younger at baseline. Annual decline rates in central retinal function were small. CONCLUSIONS: We conclude that the severity of the different disease-causing PDE6A mutations in humans with respect to central visual function may be ranked as follows: c.2053G>A/p.V685M in homozygous state (most severe) > c.998+1G>A/p.? in homozygous state > c.304C>A/p.R102S and c.2053G>A/p.V685M in compound-heterozygous state > c.304C>A/p.R102S in homozygous state (mildest). The assessment of treatment efficacy in interventional trials will remain challenging due to small annual decline rates in central retinal function.

来源:Invest Ophthalmol Vis Sci,查看原文。版权归原作者所有。

引用

  1. Kuehlewein L, Straßer T, Blumenstock G, et al. Central Visual Function and Genotype-Phenotype Correlations in PDE6A-Associated Retinitis Pigmentosa. Invest Ophthalmol Vis Sci. 2022. PMID: 35533076. doi:10.1167/iovs.63.5.9

供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。